These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37874315)

  • 1. Meta-analysis and cost-effectiveness analysis of intranasal corticosteroid treatment in allergic rhinitis with ocular symptoms.
    Yan C; Phinyo P; Mahakkanukrauh B; Bunupuradah T; Verma M; Phansalkar A; Aggarwal B
    Asian Pac J Allergy Immunol; 2023 Dec; 41(4):263-272. PubMed ID: 37874315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference evaluation and perceived sensory comparison of fluticasone furoate and mometasone furoate intranasal sprays in allergic rhinitis.
    Yonezaki M; Akiyama K; Karaki M; Goto R; Inamoto R; Samukawa Y; Kobayashi R; Kobayashi E; Hoshikawa H
    Auris Nasus Larynx; 2016 Jun; 43(3):292-7. PubMed ID: 26498699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of corticosteroid nasal sprays in relation to concomitant use and cost of other prescription medications to treat allergic rhinitis symptoms: retrospective cohort analysis of pharmacy claims data.
    Garris C; Shah M; D'Souza A; Stanford R
    Clin Drug Investig; 2009; 29(8):515-26. PubMed ID: 19591513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
    Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies.
    Meltzer EO; Tripathy I; Máspero JF; Wu W; Philpot E
    Clin Drug Investig; 2009; 29(2):79-86. PubMed ID: 19133703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):272-9. PubMed ID: 18434976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost.
    Herman H
    Am J Rhinol; 2007; 21(1):70-9. PubMed ID: 17283565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
    Int Forum Allergy Rhinol; 2019 Jan; 9(1):72-78. PubMed ID: 30179317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate.
    Ridolo E; Barone A; Nicoletta F; Paoletti G; Heffler E; Malvezzi L; Canonica GW
    Expert Rev Clin Immunol; 2023 Jun; 19(6):575-584. PubMed ID: 37038974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data.
    Scadding GK; Keith PK
    Expert Opin Pharmacother; 2008 Oct; 9(15):2707-15. PubMed ID: 18803457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis.
    Reissman D; Price T; Leibman CW
    J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of mometasone furoate versus beclomethasone dipropionate for the treatment of pediatric allergic rhinitis in Colombia.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Vladimir Lemos E
    Adv Ther; 2015 Mar; 32(3):254-69. PubMed ID: 25754327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of fluticasone furoate nasal spray for perennial allergic rhinitis in children: a comprehensive review.
    Rivera PA
    Int J Technol Assess Health Care; 2023 Jun; 39(1):e35. PubMed ID: 37325979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis.
    Han D; Liu S; Zhang Y; Wang J; Wang D; Kong W; Wang S; Cheng L; Zhang L;
    Allergy Asthma Proc; 2011; 32(6):472-81. PubMed ID: 21888757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
    Wu EL; Harris WC; Babcock CM; Alexander BH; Riley CA; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):18-27. PubMed ID: 30779679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone furoate. A review of its intranasal use in allergic rhinitis.
    Onrust SV; Lamb HM
    Drugs; 1998 Oct; 56(4):725-45. PubMed ID: 9806113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
    Stanaland BE
    Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
    Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
    Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.